A Study of AK131 in Patients With Advanced Solid Tumors

Status:
Recruiting

Trial end date:
2028-12-01

Target enrollment:

Participant gender:

This is a phase Ia/Ib study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of AK131 in advanced solid tumor patients

Phase 1

Akeso